We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Dasatinib Combination for Chronic Lymphocytic Leukemia(CLL) With Refractory Disease (D'ACCORD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01051115
Recruitment Status : Unknown
Verified August 2011 by A.P. Kater, Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA).
Recruitment status was:  Recruiting
First Posted : January 18, 2010
Last Update Posted : August 31, 2011
Sponsor:
Information provided by (Responsible Party):
A.P. Kater, Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : January 2013
  Estimated Study Completion Date : January 2016